Unraveling Chiral Recognition for Ofloxacin Enantiomers: An IMS-MS Study Enabled by Noncovalent Complexation and Theoretical Modeling
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c07410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xue Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The First Affiliated Hospital of Ningbo University, Ningbo University, No. 59, Liudin Street, Haishu District, Ningbo, Zhej…. Hauptthemen laut MEDLINE: Ofloxacin. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Ningbo Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The precise analysis of chiral drugs is crucial for elucidating their stereoselective pharmacological effects. As a commonly used fluoroquinolone antibiotic, ofloxacin (OFLX) exhibits different pharmacodynamics between its R- and S-OFLX, highlighting the need for efficient chiral analysis methods. This study developed a strategy based on trapped ion mobility spectrometry-mass spectrometry (TIMS-MS) and noncovalent complex formation for the rapid separation and quantification of ofloxacin enantiomers. Vancomycin and gentamicin C1a were selected as chiral selectors to form binary noncovalent complexes with the target enantiomers. TIMS analysis demonstrated that the complexes formed between R-/S-OFLX and both chiral selectors achieved baseline separation, with peak-to-peak resolution values of 1.94 and 3.34, respectively. To clarify the structural basis of chiral recognition, density functional theory calculations and the independent gradient model were employed, revealing key stereospecific weak interactions within the complexes, thereby providing critical atomic-level insight into the differential migration behavior observed in TIMS experiments at the molecular level. Based on these findings, both relative and absolute quantification methods for the enantiomers were established, both demonstrating excellent linearity and high sensitivity. Finally, the method was successfully applied to determine ofloxacin in artificial urine samples, achieving recoveries of no less than 70.60%, confirming its applicability in complex real-world matrices. This derivatization-free approach provides a robust and efficient solution for the rapid analysis of chiral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, The First Affiliated Hospital of Ningbo University, Ningbo University, No. 59, Liudin Street, Haishu District, Ningbo, Zhejiang Province 315010, China.
- Institute of Mass Spectrometry, School of Material Science and Chemical Engineering, Ningbo University, Ningbo, Zhejiang 315211, China.
- Department of Neonatology, The First Affiliated Hospital of Ningbo University, Ningbo University, No. 59, Liudin Street, Haishu District, Ningbo, Zhejiang Province 315010, China.
ORCID-Profile: Fangling Wu, Li Ding, Chuan-Fan Ding
Förderung
- Natural Science Foundation of Ningbo Municipality
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Yang, X., Pan, Y., Wu, N., Ding, H., Wu, F., Ding, L., & Ding, C. F. (2026). Unraveling Chiral Recognition for Ofloxacin Enantiomers: An IMS-MS Study Enabled by Noncovalent Complexation and Theoretical Modeling. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c07410
Vancouver
Yang X, Pan Y, Wu N, Ding H, Wu F, Ding L, et al. Unraveling Chiral Recognition for Ofloxacin Enantiomers: An IMS-MS Study Enabled by Noncovalent Complexation and Theoretical Modeling. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c07410
BibTeX
@article{Yang2026,
author = {Yang, Xue and Pan, Yao and Wu, NaiSheng and Ding, Huiqing and Wu, Fangling and Ding, Li and Ding, Chuan-Fan},
title = {Unraveling Chiral Recognition for Ofloxacin Enantiomers: An IMS-MS Study Enabled by Noncovalent Complexation and Theoretical Modeling},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c07410}
}
EUVIMED